Home > Cashflow Statement > GLAND PHARMA

GLAND PHARMA
Cash Flow from Operating Activities

    Back to Cashflow Statement
GLAND PHARMA is part of below Screeners ↓
Top Mid Cap Stocks with Best Fundamentals
Best 1M Momentum Mid Cap Stocks
COMMUNITY POLL
for GLAND PHARMA
Please provide your vote to see the results

GLAND PHARMA Last 5 Year Cash Flow from Operating Activities History

[Consolidated]

Mar2026Mar2025Mar2024Mar2023Mar2022
Cash Flow from Operating Activities ₹1,031 Cr₹915 Cr₹997 Cr₹364 Cr₹791 Cr

What is the latest Cash Flow from Operating Activities ratio of GLAND PHARMA ?

The latest Cash Flow from Operating Activities ratio of GLAND PHARMA is ₹1,031 Cr based on Mar2026 Consolidated results.
Year Cash Flow from Operating Activities
Mar2026₹1,031 Cr
Mar2025₹915 Cr
Mar2024₹997 Cr
Mar2023₹364 Cr
Mar2022₹791 Cr

How is Cash Flow from Operating Activities of GLAND PHARMA Trending?

Years Cash Flow from Operating Activities % Change
Mar2026 ₹1,031 Cr
12.75
Mar2025 ₹915 Cr
-8.23
Mar2024 ₹997 Cr
173.87
Mar2023 ₹364 Cr
-53.97
Mar2022 ₹791 Cr -

Compare Cash Flow from Operating Activities of peers of GLAND PHARMA

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
GLAND PHARMA ₹47,171.9 Cr -1.2% 16.2% 50.2% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹450,211.0 Cr -3% -4.1% 16.7% Stock Analytics
DIVIS LABORATORIES ₹228,303.0 Cr 0.6% 17.5% 41.9% Stock Analytics
TORRENT PHARMACEUTICALS ₹189,233.0 Cr 1.7% -0.6% 35.5% Stock Analytics
CIPLA ₹115,672.0 Cr -2% -0.7% -4.9% Stock Analytics
DR REDDYS LABORATORIES ₹98,533.5 Cr -1.5% -3.5% -2.2% Stock Analytics


GLAND PHARMA Share Price vs Sensex

Share Price Returns(%) 1 Week 1 Month 1 Year
GLAND PHARMA

-1.2%

16.2%

50.2%

SENSEX

-1.2%

-1.2%

-3.3%


You may also like the below Video Courses